Extending inflamed-class signature to predict immune checkpoint inhibitor-based combination therapy in hepatocellular carcinoma
Wenhua You(Nanjing Medical University), Yun Chen(Jiangsu Cancer Hospital), Yedi Huang(Jiangsu Cancer Hospital), Yuhan Zhang(Nanjing Medical University), Ling Li(Dalian Medical University), Jinying Lu(Jiangsu Cancer Hospital), Mengya Zhao(Jiangsu Cancer Hospital), Chupeng Hu(Jiangsu Cancer Hospital)
Cited by 5
Related Papers
Gut microbiota–derived short‐chain fatty acids regulate group 3 innate lymphoid cells in HCC
|Hepatology|2022|181
Gastric Microbiome Alterations Are Associated with Decreased CD8+ Tissue-Resident Memory T Cells in the Tumor Microenvironment of Gastric Cancer
|Cancer Immunology Research|2022|120
Important role of the SDF-1/CXCR4 axis in the homing of systemically transplanted human amnion-derived mesenchymal stem cells (hAD-MSCs) to ovaries in rats with chemotherapy-induced premature ovarian insufficiency (POI)
|Stem Cell Research & Therapy|2022|96